The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nuclear Cardiology-Global Market Insights and Sales Trends 2024
Synopsis
Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
The global Nuclear Cardiology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nuclear Cardiology in various end use industries. The expanding demands from the Hospitals, Clinics, Academic and Research Institutes and Others, are propelling Nuclear Cardiology market. Radiology Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiology Information Systems (RIS) segment is estimated at % CAGR for the next seven-year period.
Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nuclear Cardiology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nuclear Cardiology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nuclear Cardiology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nuclear Cardiology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nuclear Cardiology covered in this report include GE Healthcare, Shimadzu, Siemens Healthcare, Fujifilm Medical, Astellas Pharma, Philips Healthcare, Medtronic, 3mensio Medical Imaging and Bracco Diagnostics, etc.
The global Nuclear Cardiology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Shimadzu
Siemens Healthcare
Fujifilm Medical
Astellas Pharma
Philips Healthcare
Medtronic
3mensio Medical Imaging
Bracco Diagnostics
UltraSPECT
Global Nuclear Cardiology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nuclear Cardiology market, Segment by Type:
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
Global Nuclear Cardiology market, by Application
Hospitals
Clinics
Academic and Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nuclear Cardiology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
The global Nuclear Cardiology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nuclear Cardiology in various end use industries. The expanding demands from the Hospitals, Clinics, Academic and Research Institutes and Others, are propelling Nuclear Cardiology market. Radiology Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiology Information Systems (RIS) segment is estimated at % CAGR for the next seven-year period.
Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nuclear Cardiology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nuclear Cardiology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nuclear Cardiology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nuclear Cardiology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nuclear Cardiology covered in this report include GE Healthcare, Shimadzu, Siemens Healthcare, Fujifilm Medical, Astellas Pharma, Philips Healthcare, Medtronic, 3mensio Medical Imaging and Bracco Diagnostics, etc.
The global Nuclear Cardiology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Shimadzu
Siemens Healthcare
Fujifilm Medical
Astellas Pharma
Philips Healthcare
Medtronic
3mensio Medical Imaging
Bracco Diagnostics
UltraSPECT
Global Nuclear Cardiology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nuclear Cardiology market, Segment by Type:
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
Global Nuclear Cardiology market, by Application
Hospitals
Clinics
Academic and Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nuclear Cardiology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nuclear Cardiology
1.1 Nuclear Cardiology Market Overview
1.1.1 Nuclear Cardiology Product Scope
1.1.2 Nuclear Cardiology Market Status and Outlook
1.2 Global Nuclear Cardiology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nuclear Cardiology Market Size by Region (2018-2029)
1.4 Global Nuclear Cardiology Historic Market Size by Region (2018-2023)
1.5 Global Nuclear Cardiology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nuclear Cardiology Market Size (2018-2029)
1.6.1 North America Nuclear Cardiology Market Size (2018-2029)
1.6.2 Europe Nuclear Cardiology Market Size (2018-2029)
1.6.3 Asia-Pacific Nuclear Cardiology Market Size (2018-2029)
1.6.4 Latin America Nuclear Cardiology Market Size (2018-2029)
1.6.5 Middle East & Africa Nuclear Cardiology Market Size (2018-2029)
2 Nuclear Cardiology Market by Type
2.1 Introduction
2.1.1 Radiology Devices
2.1.2 Radiology Information Systems (RIS)
2.1.3 Radiopharmaceuticals
2.2 Global Nuclear Cardiology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nuclear Cardiology Historic Market Size by Type (2018-2023)
2.2.2 Global Nuclear Cardiology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
3 Nuclear Cardiology Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academic and Research Institutes
3.1.4 Others
3.2 Global Nuclear Cardiology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nuclear Cardiology Historic Market Size by Application (2018-2023)
3.2.2 Global Nuclear Cardiology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
4 Nuclear Cardiology Competition Analysis by Players
4.1 Global Nuclear Cardiology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Cardiology as of 2022)
4.3 Date of Key Players Enter into Nuclear Cardiology Market
4.4 Global Top Players Nuclear Cardiology Headquarters and Area Served
4.5 Key Players Nuclear Cardiology Product Solution and Service
4.6 Competitive Status
4.6.1 Nuclear Cardiology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Nuclear Cardiology Products, Services and Solutions
5.1.4 GE Healthcare Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Shimadzu
5.2.1 Shimadzu Profile
5.2.2 Shimadzu Main Business
5.2.3 Shimadzu Nuclear Cardiology Products, Services and Solutions
5.2.4 Shimadzu Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.2.5 Shimadzu Recent Developments
5.3 Siemens Healthcare
5.3.1 Siemens Healthcare Profile
5.3.2 Siemens Healthcare Main Business
5.3.3 Siemens Healthcare Nuclear Cardiology Products, Services and Solutions
5.3.4 Siemens Healthcare Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.3.5 Fujifilm Medical Recent Developments
5.4 Fujifilm Medical
5.4.1 Fujifilm Medical Profile
5.4.2 Fujifilm Medical Main Business
5.4.3 Fujifilm Medical Nuclear Cardiology Products, Services and Solutions
5.4.4 Fujifilm Medical Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.4.5 Fujifilm Medical Recent Developments
5.5 Astellas Pharma
5.5.1 Astellas Pharma Profile
5.5.2 Astellas Pharma Main Business
5.5.3 Astellas Pharma Nuclear Cardiology Products, Services and Solutions
5.5.4 Astellas Pharma Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.5.5 Astellas Pharma Recent Developments
5.6 Philips Healthcare
5.6.1 Philips Healthcare Profile
5.6.2 Philips Healthcare Main Business
5.6.3 Philips Healthcare Nuclear Cardiology Products, Services and Solutions
5.6.4 Philips Healthcare Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.6.5 Philips Healthcare Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic Nuclear Cardiology Products, Services and Solutions
5.7.4 Medtronic Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic Recent Developments
5.8 3mensio Medical Imaging
5.8.1 3mensio Medical Imaging Profile
5.8.2 3mensio Medical Imaging Main Business
5.8.3 3mensio Medical Imaging Nuclear Cardiology Products, Services and Solutions
5.8.4 3mensio Medical Imaging Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.8.5 3mensio Medical Imaging Recent Developments
5.9 Bracco Diagnostics
5.9.1 Bracco Diagnostics Profile
5.9.2 Bracco Diagnostics Main Business
5.9.3 Bracco Diagnostics Nuclear Cardiology Products, Services and Solutions
5.9.4 Bracco Diagnostics Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.9.5 Bracco Diagnostics Recent Developments
5.10 UltraSPECT
5.10.1 UltraSPECT Profile
5.10.2 UltraSPECT Main Business
5.10.3 UltraSPECT Nuclear Cardiology Products, Services and Solutions
5.10.4 UltraSPECT Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.10.5 UltraSPECT Recent Developments
6 North America
6.1 North America Nuclear Cardiology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nuclear Cardiology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Cardiology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nuclear Cardiology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Cardiology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nuclear Cardiology Market Dynamics
11.1 Nuclear Cardiology Industry Trends
11.2 Nuclear Cardiology Market Drivers
11.3 Nuclear Cardiology Market Challenges
11.4 Nuclear Cardiology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
